Early prediction of the failure of methotrexate treatment by Days 1–4 serum β-hCG change and 48-hour pre-treatment increment inβ-hCG

References

• Agostini, A., et al., 2007. Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy. Fertility and Sterility, 88 (2), 504–506.
   PubMed Web of Science ®Google Scholar
• Atkinson, M., Gupta, S. and Mcgee, T., 2014. betahCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the day 4 betahCG necessary? A retrospective cohort study. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 54 (5), 475–479.
   PubMed Web of Science ®Google Scholar
• Barnhart, K. T., et al., 2003. The medical management of ectopic pregnancy: a meta-analysis comparing “single dose” and “multidose” regimens. Obstetrics and Gynecology, 101 (4), 778–784.
   PubMed Web of Science ®Google Scholar
• Brunello, J., et al., 2019. Can early betahCG change and baseline progesterone level predict treatment outcome in patients receiving single dose Methotrexate protocol for tubal ectopic pregnancy? Archives of Gynecology and Obstetrics, 299 (3), 741–745.
   PubMed Web of Science ®Google Scholar
• Dai, Y., et al., 2017. Routine beta-human chorionic gonadotropin monitoring for single-dose methotrexate treatment in ectopic pregnancy. Journal of Minimally Invasive Gynecology, 24 (7), 1195–1199.
   PubMed Web of Science ®Google Scholar
• Levin, G., et al., 2018. Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment. International Journal of Gynecology & Obstetrics, 141 (1), 70–73.
   PubMed Web of Science ®Google Scholar
• Hadinata, I. E., et al., 2015. Serum beta-hCG levels post-treatment of ectopic pregnancy with a single dose of intramuscular methotrexate. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 55 (2), 181–184.
   PubMed Web of Science ®Google Scholar
• Levin, G., et al., 2019. Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG. Reproductive Biomedicine Online, 39 (1), 149–154.
   PubMed Web of Science ®Google Scholar
• Lipscomb, G. H., et al., 1999. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. The New England Journal of Medicine, 341 (26), 1974–1978.
   PubMed Web of Science ®Google Scholar
• Mashiach, R., et al., 2018. Significant increase in serum hCG levels following methotrexate therapy is associated with lower treatment success rates in ectopic pregnancy patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 231, 188–191.
   PubMed Web of Science ®Google Scholar
• Mirbolouk, F., Yousefnezhad, A. and Ghanbari, A., 2015. Predicting factors of medical treatment success with single dose methotrexate in tubal ectopic pregnancy: a retrospective study. Iranian Journal of Reproductive Medicine, 13 (6), 351–354.
   PubMedGoogle Scholar
• Nguyen, Q., et al., 2010. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy? American Journal of Obstetrics and Gynecology, 202 (6), 630 e1–630.e5.
   Web of Science ®Google Scholar
• Shatkin Hamish, N., et al., 2020. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels. Journal of Obstetrics and Gynaecology Research, 46 (7), 1104–1109.
   PubMed Web of Science ®Google Scholar
• Skubisz, M., et al., 2013. Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC Pregnancy and Childbirth, 13 (1), 30.
   PubMedGoogle Scholar
• Song, T., et al., 2016. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial. Human Reproduction, 31 (2), 332–338.
   PubMed Web of Science ®Google Scholar
• Stovall, T. G., Ling, F. W. and Gray, L. A., 1991. Single-dose methotrexate for treatment of ectopic pregnancy. Obstetrics and Gynecology, 77 (5), 754–757.
   PubMed Web of Science ®Google Scholar
• Tasgoz, F. N., et al., 2020. The role of day 0 and day 4 beta-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy. Ginekologia Polska, 91 (7), 389–393.
   PubMed Web of Science ®Google Scholar
• Ustunyurt, E., et al., 2013. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy. Archives of Gynecology and Obstetrics, 288 (5), 1149–1152.
   PubMed Web of Science ®Google Scholar